Archived Medical News Stories

<< Back to Main Archives Index

RSSArchived Pharmaceutical News Stories - September 2004

Date Title Comments Rating
2004-09-30 Australian nanotech Starpharma to develop a second generation microbicide for the prevention of infection by HIV 0 None
2004-09-29 ID Biomedical awarded US$9.5 million to develop its cell culture-based influenza vaccine 0 None
2004-09-29 Biomira and Merck announce fast track status for liposome vaccine 0 None
2004-09-29 Schwarzenegger signs AIDS Pharmacy Bill 0 None
2004-09-28 Chiron CEO to appear before the U.S. Senate Special Committee on Aging 0 None
2004-09-28 New capsule, made from fish gelatin, should end fears of viral infections such as BSE and vCJD 0 None
2004-09-27 Half of Viagra samples purchased on the internet were fake 0 5
2004-09-26 New drug application to market ramelteon for insomnia 0 None
2004-09-26 Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets 0 None
2004-09-26 Drug companies and FDA crack down on Canadian drug importation to protect profits 0 None
2004-09-26 Drug shortages are having major negative effects on patient care and hospital costs 0 None
2004-09-26 Palladone approved for pain relief 0 None
2004-09-23 New combination of drugs results in fewer incidences of rejection in liver transplant patients 0 None
2004-09-23 PA Consulting sells drug delivery venture, Meridica, to Pfizer 0 None
2004-09-22 Glaxo drops appeal in AIDS drug pricing case 0 None
2004-09-22 GlaxoSmithKline has granted a voluntary licence to Cosmos Limited for the manufacture and sale of antiretrovirals 0 None
2004-09-22 Aventis Pasteur to manufacture and store 2 million doses of avian influenza H5N1 vaccine 0 None
2004-09-20 Data suggests potential role of Quadramet in conjunction with chemotherapy for the treatment of acute myeloid leukemia 0 None
2004-09-20 Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly 0 None
2004-09-20 Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe 0 None
2004-09-20 European positive for Cymbalta and Xeristar 0 None
2004-09-20 Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine 0 None
2004-09-16 Wyeth supports FDA recommendation to strengthen antidepressant labeling 0 None
2004-09-14 Prozac, Paxil, Wellbutrin, Zoloft, Celexa, Effexor, Luvox and Remeron should have "Black Box" warnings 1 5
2004-09-14 ID Biomedical to supply meningitis C vaccine to the Canadian government 0 None
2004-09-14 Which provincial pharmacare system works best to protect Canadians against catastrophic drug costs? 0 None
2004-09-13 Potential new drug for the treatment of sickle cell disease 0 None
2004-09-13 Yentreve available in Europe for treatment of stress urinary incontinence 0 None
2004-09-08 Phase I clinical trial of new drug for severe asthma 0 None
2004-09-08 Cymbalta approved for diabetic peripheral neuropathy pain 0 None
2004-09-07 FDA approval for chewable ADHD tablets 0 None
2004-09-07 Topiramate help patients with alcohol dependence 0 None
2004-09-07 Ezetrol co-administration with statin therapy lowers LDL cholesterol in diabetics 0 None
2004-09-06 Phico Therapeutics secures funding to tackle superbug 0 None
2004-09-05 More than 100 million doses of influenza vaccine available this year in the United States 0 None
2004-09-02 Pfizer files lawsuits against eighteen internet sites for selling illegal copies of LIPITOR 0 None
2004-09-02 New drug application for exenatide has been accepted for review 0 None
2004-09-01 MGI PHARMA acquires Aesgen for $32 million 0 None

Total

38 posts
1 comments
2 raters